Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 319

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 319
---
 statement/prospectus, they might include, without limitation, arrangements to protect such persons against potential loss in value of their shares, including the granting of put options and the transfer to such persons of shares or warrants for nominal value. BLAC’s Sponsor, directors, officers or their respective affiliates will not affect any such purchases when they are in possession of any material non -publicinformation relating to BLAC or OSR Holdings, during a restricted period under Regulation M under the Exchange Act or in a transaction which would violate Section 9(a)(2) or Rule 10(b) -5under the Exchange Act. The purpose of such purchases and other transactions would be to increase the likelihood that the Business Combination Proposal is approved and to decrease the likelihood that holders request redemption of public shares and cause BLAC to be unable to consummate the Business Combination. If BLAC’s Sponsor, directors, officers or their respective affiliates effect any purchases of shares of BLAC Common Stock, such purchases may cause the Business Combination Proposal or any other proposal to be approved in circumstances where such approval could not otherwise be obtained. As of the date of this proxy statement/prospectus, no such agreements to sell or purchase shares prior to the Record Date have been entered into with any such investor or holder. BLAC will file a Current Report on Form 8 -Kto disclose any material arrangements entered into or significant purchases made by any of the aforementioned persons that are not described in this proxy statement and that would affect the vote on the Business Combination Proposal. See “ Risk Factors — Risks Related to the Business Combination and Business Combination Agreement — The Sponsor and its affiliates may enter into agreements concerning BLAC’s securities prior to the special meeting, which may have the effect of increasing the likelihood of completion of the Business Combination or decreasing the value of BLAC Common Stock.” 192 Regulatory Approvals Required for the Business Combination Other than as described immediately below, neither of BLAC or OSR Holdings is aware of any material regulatory approvals or actions that are required for completion of the Business Combination. It is presently contemplated that if any regulatory approvals or actions are required, those approvals or actions will be sought. There can be no assurance, however, that any additional approvals or actions will be obtained. Because BLAC’s Sponsor is controlled by and has substantial ties with non -U.S. persons, and will own approximately 11.6% of the issued and outstanding BLAC Common Stock following the Business Combination (assuming that all of BLAC’s public stockholders exercise redemption rights), we may be